Results 151 to 160 of about 31,379 (232)
ABSTRACT Background Endoscopic full‐thickness resection (EFTR) using the full‐thickness resection device (FTRD) is an emerging technique for the management of complex colorectal lesions and early colorectal cancers. Although EFTR offers a minimally invasive alternative to surgery, data on efficacy, safety, and predictors of adverse events (AEs) remain ...
Vicki McGarrigle +20 more
wiley +1 more source
Can Spleen T1 Mapping Be Used as a Marker of Adenosine Response in Cardiac MRI?
Patients with suspected coronary artery disease were scanned at 1.5 T with the routine clinical protocol for CMR. T1 mapping sequence at rest and during stress was included in which the spleen was visible. Splenic switch‐off was visually assessed in first‐pass images.
Sergio M. Solis‐Barquero +6 more
wiley +1 more source
ABSTRACT Adult‐onset Still's disease (AOSD) is an auto inflammatory disorder with a variable clinical presentation, and without a pathognomonic diagnostic test, characterized by high spiking fever, arthralgia/arthritis, a suggestive skin rash, elevated white blood cell count 10 G/L (> 80% neutrophils), elevated ferritin, with glycosylated ferritin < 20%
M. Nordmann +7 more
wiley +1 more source
Amyloidosis of the Larynx [PDF]
R T, Sataloff +4 more
openaire +2 more sources
Memory Services for People With Down Syndrome: A Scoping Review Exploring Models of Care and Access
ABSTRACT More than 95% of people with Down syndrome develop Alzheimer's disease (AD), with a median age of diagnosis of approximately 54 years. However, there is a significant gap in guidance regarding the design of effective memory services and tailored diagnostic pathways.
M. Healy +3 more
wiley +1 more source
Clinical Characteristics of Amyloidosis
Background: Amyloidosis is a rare disease that amyloid fibril deposit in multiple organic tissue and decrease organic functions. Many case reports for amyloidosis were published but it is rare to domestic generalized report for amyloidosis.
김주성 +10 more
core
Abstract Anti‐B cell maturation antigen (BCMA) therapies, including antibody‐drug conjugates, chimeric antigen receptor T cells, and bispecific antibodies (bsAbs), have recently revolutionized the treatment landscape of multiple myeloma. This review outlines the biologic rationale for targeting BCMA and sheds light on the mechanism of action of bsAbs ...
Enrica Manzato +5 more
wiley +1 more source

